EarGenie, an innovative test to measure speech discrimination using functional near-infrared spectroscopy

EarGenie is an innovative hearing test utilizing fNIRS (functional near-infrared light) technology to measure the brain's response to sound. By detecting variations in the brain's hemodynamic response to auditory stimuli, EarGenie can effectively assess a baby's hearing capabilities. Current audiology practices primarily rely on electrophysiology measures to determine hearing thresholds in infants. This approach poses limitations when it comes to accurately assessing infants with auditory neuropathy. There is no measure of speech discrimination for the paediatric population currently in the clinical setting, which can lead to uncertainties and challenges in providing appropriate care. The EarGenie will fulfill this unmet need to provide clinicians with an objective measure of speech discrimination. Improved clarity for clinicians and families of the diagnosis and management of infants with hearing loss is required to optimize audiology practices.